#QNTM-SEC-Update-(04-SEP-2025)-ThinkSabio-Stocks Simplified)
SEC Filing Update: #QNTM : $14.29 Sector: Healthcare | YTD: 🔼+ 77.52 % The SEC...
September 4, 2025
#PLRX-SEC-Update-(04-SEP-2025)-ThinkSabio-Stocks Simplified)
SEC Filing Update: #PLRX : $1.75 Sector: Healthcare | YTD: 🔼+ 27.74 % The SEC...
#OCG-SEC-Update-(04-SEP-2025)-ThinkSabio-Stocks Simplified)
SEC Filing Update: #OCG : $4.17 Sector: Consumer Cyclical | YTD: 🔼+ 25.98 % The...
#GPUS-SEC-Update-(04-SEP-2025)-ThinkSabio-Stocks Simplified)
SEC Filing Update: #GPUS : $0.41 Sector: Industrials | YTD: 🔽 -82.33 % The SEC...
#PRQR-SEC-Update-(04-SEP-2025)-ThinkSabio-Stocks Simplified)
SEC Filing Update: #PRQR : $2.39 Sector: Healthcare | YTD: 🔼+ 83.85 % The SEC...
#CRI-SEC-Update-(04-SEP-2025)-ThinkSabio-Stocks Simplified)
SEC Filing Update: #CRI : $28.62 Sector: Consumer Cyclical | YTD: 🔽 -30.30 % The...
Gain Therapeutics Inc Stock price, Description, News & Info
#Thinksabio latest news Gain Therapeutics Receives Australian Approval of Phase 1b Dosing Extension and Reports...
StoneX Group Inc. (SNEX) Stock price, Description, News & Info
#Thinksabio latest news StoneX Acquires Right Corp, Expanding Global Trading Capabilities to Include Wholesale Meat...
POET Technologies Inc. (POET) Stock price, Description, News & Info
#Thinksabio latest news POET Technologies to Showcase Breakthrough Light Source and 1.6T Optical Engines for...
MBX Biosciences, Inc. (MBX) Stock price, Description, News & Info
#Thinksabio latest news MBX Biosciences Doses First Participant in Phase 1 Trial of MBX 4291...